Omeprazole Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 20 mg, 40 mg
Reference Brands: Prilosec(US & EU)
Category:
Medical Aid
Omeprazole tablets work by irreversibly inhibiting the gastric H⁺/K⁺ ATPase enzyme in stomach lining cells, reducing acid production. Benefits include relief from acid reflux, gastroesophageal reflux disease (GERD), and ulcers, promoting healing of the esophagus and stomach, and preventing acid-related damage and discomfort.
Omeprazole tablets is available in Tablet
and strengths such as 20 mg, 40 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Omeprazole tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Omeprazole tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Omeprazole tablets are approved in both the US and EU, with regulatory oversight from the FDA and EMA. These products are supported by detailed dossiers demonstrating safety, efficacy, and manufacturing quality under GMP standards. In the US, Prilosec is a leading branded formulation, while in the EU, generic and branded versions like Losec are common. Regulatory approval involves rigorous clinical evaluation and documentation. For comprehensive information on licensing, approved dossiers, and regulatory requirements for omeprazole tablets, visit Pharmatradz. Stay updated on the latest regulatory developments and licensing processes for omeprazole in global markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing